ZLAB Q4 2023 Earnings — Zai Lab Limited Revenue & Financial Results | Market Cap Arena

ZLABZai Lab Limited

$2B

Q4 2023 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$66M+5.2% YoY

Gross Profit

$41M61.7% margin

Operating Income

-$124M-188.3% margin

Net Income

-$95M-145.0% margin

EPS (Diluted)

$-9.80

QoQ Revenue Growth

-4.9%

Cash Flow

Operating Cash Flow

-$15M

Free Cash Flow

-$15M

Stock-Based Comp.

$20M

Balance Sheet

Total Assets

$1.0B

Total Liabilities

$240M

Stockholders' Equity

$796M

Cash & Equivalents

$790M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$66M	$63M	+5.2%
Gross Profit	$41M	$42M	-2.6%
Operating Income	-$124M	-$97M	-27.4%
Net Income	-$95M	-$62M	-54.5%

Revenue Segments

Zejula

$42M68%

Optune

$8M14%

Nuzyra

$6M10%

Qinlock

$5M8%